Widening of myelin lamellae in polyneuropathy with immunoglobulin-M monoclonal gammopathy, without activity against myelin-associated glycoprotein, responsive to treatment - Laboratoire des Agroressources, Biomolécules et Chimie pour l’Innovation en Santé
Article Dans Une Revue Neuromuscular Disorders Année : 2022

Widening of myelin lamellae in polyneuropathy with immunoglobulin-M monoclonal gammopathy, without activity against myelin-associated glycoprotein, responsive to treatment

Résumé

We report the case of a patient with a very severe predominantly demyelinating sensorimotor polyneuropathy (with axonal loss) that had developed over several months, along with an immunoglobulin-M monoclonal gammopathy without anti-myelin associated glycoprotein antibodies (or other antibodies against myelin). Widening of myelin lamellae were frequently observed by electron microscopic examination of a nerve biopsy: immunoglobulin-M targeting an unknown myelin antigen appears to be responsible for the nerve lesions similar to those observed in anti-myelin associated glycoprotein polyneuropathy. Usually, if in anti-myelin associated glycoprotein neuropathy the response to immunotherapies is not optimal, in this case the combination of plasma exchanges and rituximab was effective, suggesting an autoimmune origin.
Fichier principal
Vignette du fichier
WML no anti-MAG.pdf (740.12 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04777575 , version 1 (12-11-2024)

Identifiants

Citer

Jean-Michel Vallat, Nathalie Deschamps, Laurence Richard, Laurent Magy, Jérôme J. Devaux, et al.. Widening of myelin lamellae in polyneuropathy with immunoglobulin-M monoclonal gammopathy, without activity against myelin-associated glycoprotein, responsive to treatment. Neuromuscular Disorders, 2022, 32 (8), pp.678-681. ⟨10.1016/j.nmd.2022.05.001⟩. ⟨hal-04777575⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More